CHARLES W NEWHALL III Insider Trading $VTAE Vitae Pharmaceuticals, Inc

Get the latest insider transactions of CHARLES W NEWHALL III. CHARLES W NEWHALL III is Director in PHARMOS CORP ($PARS) and 10% Owner in APPLIED IMAGING CORP ($AICX) and 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in NETSOLVE INC ($NTSL) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in OCCAM NETWORKS INC/DE ($OCCM) and in ZHONE TECHNOLOGIES INC ($ZHNE) and 10% Owner in ZHONE TECHNOLOGIES INC ($ZHNE) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and in PHARMION CORP ($PHRM) and 10% Owner in PHARMION CORP ($PHRM) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and in FOXHOLLOW TECHNOLOGIES, INC. ($FOXH) and 10% Owner in FOXHOLLOW TECHNOLOGIES, INC. ($FOXH) and Director in Vitae Pharmaceuticals, Inc ($VTAE) and 10% Owner in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in INTERCELL USA, INC. ($IOMI) and 10% Owner in INNERWORKINGS INC ($INWK) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN).